648: In this interview, Diogo Rau, CIDO of Eli Lilly, discusses with Peter High the areas of opportunity in the drug discovery industry that technology has helped accelerate. He starts with his strategic priorities in his first year as CIDO and what attracted him to this complex industry. Diogo then expands upon the data strategy of the company and how machine learning is accelerating drug discovery. Finally, he talks about how he has harnessed the talent in the Indianapolis area, long-lasting changes from the pandemic, and the keys to success in Diogo’s diverse career.